📰 Weekly Newspaper

WHY: AB broke below its 200-day MA amid a 5% drop and heavy volume, pre-Q2 earnings volatility⁹¹⁴¹⁵ WHO: No recent analyst rating changes, insider buys >$1M, or notable 13D/F filings detected¹³ RISK: Upcoming July 28 earnings could trigger a bullish reversal and squeeze this short setup¹⁵

WHY: consolidation move, no clear catalyst; the latest material driver was a July AI compute contract/2026 cash-flow outlook. ¹² WHO: no tracked smart-money activity; no recent analyst change or insider/13D-F signal in results. ³⁶ RISK: July 17 noted as earnings on Aug. 13, so the next binary print can cap upside or break the bounce. ⁴

WHY: Positive TH103 Phase 1a data on Jul 11 drove a 29% KLRS surge; now it’s fading off that biotech pop.¹⁵ WHO: No tracked smart-money activity; no analyst changes or >$1M insider/13-D/F signals surfaced in results. RISK: Next earnings Aug 12, 2026 leaves an event gap, but the stock can squeeze on more TH103 follow-through.¹⁰¹⁵